<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-127216" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Enterococcus Infections</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Said</surname>
            <given-names>Mina S.</given-names>
          </name>
          <aff>Rochester General Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tirthani</surname>
            <given-names>Ekta</given-names>
          </name>
          <aff>Rochester General Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Lesho</surname>
            <given-names>Emil</given-names>
          </name>
          <aff>Rochester Regional Health</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Mina Said declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ekta Tirthani declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Emil Lesho declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>12</day>
          <month>2</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-127216.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Enterococci are Gram-positive facultative anaerobic cocci in short and medium chains, which cause difficult-to-treat infections in the nosocomial setting. They are a common cause of UTIs, bacteremia, and infective endocarditis and rarely cause intra-abdominal infections and meningitis. They have intrinsic resistance to some antibiotics and acquire and transfer resistance to other bacteria via mobile genetic elements. Their detection is aided by conventional Gram stain and cultures and newer techniques like MALDI-TOF, NAAT, and PCR. Antibiotic sensitivities should be obtained early on to help physicians formulate treatment plans. To avoid the high morbidity and mortality associated with this condition, it must be promptly diagnosed and treated. This activity reviews the evaluation and treatment of enterococcal infections and highlights the role of the interprofessional team in preventing the hospital-related spread of enterococci, especially VRE.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Compare the diseases caused by enterococci.</p></list-item><list-item><p>Identify the mechanism of resistance of enterococcus to commonly used antibiotics.</p></list-item><list-item><p>Identify the various treatment regimens used for enterococcal infections.</p></list-item><list-item><p>Identify how interprofessional team strategies can result in better care coordination for patients presenting with an enterococcal infection.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=127216&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=127216">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-127216.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Enterococci are Gram-positive facultative anaerobic cocci in short and medium chains, first discovered in 1899 in the human gastrointestinal tract. They were recognized as a separate genus from streptococci by DNA hybridization and 16S rRNA sequencing in 1984.<xref ref-type="bibr" rid="article-127216.r1">[1]</xref>&#x000a0;They are the first of the ESKAPE organisms (<italic toggle="yes">Enterococci</italic> spp., <italic toggle="yes">Staphylococcus aureus</italic>, <italic toggle="yes">Klebsiella pneumoniae</italic>, <italic toggle="yes">Acinetobacter baumannii</italic>,<italic toggle="yes"> Pseudomonas aeruginosa</italic>, <italic toggle="yes">Enterobacter</italic> spp.) highlighted by the WHO as rising causes of nosocomial and antibiotic-resistant infections in the last few decades threatening public health.<xref ref-type="bibr" rid="article-127216.r2">[2]</xref></p>
        <p>Vancomycin-resistant enterococci (VRE) were first reported in 1933 in animals owing to avoparcin, a vancomycin analog used as an animal food additive. However, they were reported for the first time in humans in England in 1988, several years later.<xref ref-type="bibr" rid="article-127216.r3">[3]</xref><xref ref-type="bibr" rid="article-127216.r4">[4]</xref></p>
      </sec>
      <sec id="article-127216.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Enterococci are found in the soil, water, food, sewage, plants, human skin, the oral cavity, and the large intestine, constituting less than 1% of the total microbiota.<xref ref-type="bibr" rid="article-127216.r3">[3]</xref></p>
        <p>There are about 58 species recognized of enterococci so far, the most important and common being <italic toggle="yes">E. faecalis</italic> and <italic toggle="yes">E .faecium.</italic><xref ref-type="bibr" rid="article-127216.r5">[5]</xref>&#x000a0;Others include <italic toggle="yes">E. avium</italic>,<italic toggle="yes"> E. caccae</italic>, <italic toggle="yes">E. casseliflavus</italic>, <italic toggle="yes">E. dispar</italic>, <italic toggle="yes">E. durans</italic>, <italic toggle="yes">E. gallinarum</italic>, <italic toggle="yes">E. hirae</italic>, and <italic toggle="yes">E. raffinosus</italic>. These so-called non-faecium non-faecalis enterococci are increasingly recognized in reports as causes of the bloodstream and endovascular infections in humans nowadays.<xref ref-type="bibr" rid="article-127216.r6">[6]</xref><xref ref-type="bibr" rid="article-127216.r7">[7]</xref><xref ref-type="bibr" rid="article-127216.r8">[8]</xref></p>
        <p>Enterococci are highly resilient and can survive difficult conditions like common antiseptics and disinfectants, promoting their widespread&#x000a0;persistence on ordinary hospital inanimate items.<xref ref-type="bibr" rid="article-127216.r1">[1]</xref><xref ref-type="bibr" rid="article-127216.r4">[4]</xref>&#x000a0;Moreover, they are easily transmissible&#x000a0;via the hands of healthcare workers (HCWs).<xref ref-type="bibr" rid="article-127216.r9">[9]</xref></p>
        <p>Enterococcal colonization of the gastrointestinal (GI) tract is the main predisposing factor for severe infections, which occur through gut translocation. Enterococci are phagocytosed and transported across the intestinal wall and resist killing by the lymph system.<xref ref-type="bibr" rid="article-127216.r10">[10]</xref>&#x000a0;</p>
        <p>The risk of VRE colonization and infections is associated with previous antibiotic exposure disrupting normal gut microbiomes, especially vancomycin, and cephalosporins. In addition, prolonged hospitalization, ICU stays, residence in long-term care (LTC) facilities, hemodialysis patients, diabetes, cancer, and transplant patients, stomach acid suppression, use of invasive devices, and exposure to contaminated surfaces, including shared medical equipment can also predispose individuals to get enterococci/VRE infections.<xref ref-type="bibr" rid="article-127216.r11">[11]</xref><xref ref-type="bibr" rid="article-127216.r12">[12]</xref></p>
      </sec>
      <sec id="article-127216.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Currently, enterococci rank second in the USA, only after staphylococci, in nosocomial infections, antibiotic-resistant pathogenic diseases, central line-associated bacteremias, and hospital-associated endocarditis.<xref ref-type="bibr" rid="article-127216.r4">[4]</xref><xref ref-type="bibr" rid="article-127216.r13">[13]</xref>&#x000a0;Reports suggest that 60% of all infections by enterococci are healthcare-acquired, including in the ICU setting. Enterococci are the third most common cause of community-acquired endocarditis in North America, after <italic toggle="yes">Staphylococcus aureus</italic> and <italic toggle="yes">Streptococcus viridans</italic>, higher than anywhere else globally.<xref ref-type="bibr" rid="article-127216.r10">[10]</xref></p>
        <p>Enterococci cause 15&#x000a0;to 20% of hospital urinary tract infections (UTIs).<xref ref-type="bibr" rid="article-127216.r14">[14]</xref>&#x000a0;Currently, VRE is much less prevalent in Europe than in the USA, where they have grown to be around 30% of all enterococcal infections. There has also been a noticeable rise in the <italic toggle="yes">E. faecium</italic> species, constituting 35% of enterococcal isolates from nosocomial infections and 40% of bloodstream isolates in liver/stem cell transplant recipients.<xref ref-type="bibr" rid="article-127216.r15">[15]</xref><xref ref-type="bibr" rid="article-127216.r16">[16]</xref>&#x000a0;</p>
        <p><italic toggle="yes">E. faecium</italic> species are 80% vancomycin-resistant and 90% ampicillin-resistant compared to <italic toggle="yes">E. faecalis</italic> species, which are only 10% vancomycin-resistant and mostly ampicillin sensitive.<xref ref-type="bibr" rid="article-127216.r5">[5]</xref></p>
      </sec>
      <sec id="article-127216.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Enterococci do not produce toxins like staphylococci and streptococci, but their virulence comes from other properties like durability, structure, and antibiotic resistance.<xref ref-type="bibr" rid="article-127216.r4">[4]</xref></p>
        <p>Enterococcal surface components include the polysaccharide capsule, adhesins, pili, and the aggregation substance.<xref ref-type="bibr" rid="article-127216.r1">[1]</xref>&#x000a0;Their ability to form biofilms promotes adherence to catheters, dental prostheses, and heart valves and limits antibiotic penetration, causing persistent infections that are often even polymicrobial.<xref ref-type="bibr" rid="article-127216.r17">[17]</xref></p>
        <p>Enterococci secrete virulence factors like bacteriocins, hemolysin/cytolysin, gelatinase, and serine protease.&#x000a0;Moreover, they are also capable of producing toxic oxygen metabolites, leading to cell injury.</p>
        <p>Enterococci are intrinsically resistant to cephalosporins, clindamycin, aminoglycosides, and trimethoprim-sulfamethoxazole.<xref ref-type="bibr" rid="article-127216.r5">[5]</xref>&#x000a0;They also gain antibiotic resistance through their ability to acquire and transfer resistance-related mobile genetic elements (MGE) via various mechanisms like plasmids, conjugation, and transposons.<xref ref-type="bibr" rid="article-127216.r1">[1]</xref>&#x000a0;This latter property is believed to be due to the absence of CRISPR-Cas gene loci, which usually limit invading harmful DNA.</p>
        <table-wrap id="article-127216.table0" position="float" orientation="portrait">
          <table>
            <tbody>
              <tr>
                <td rowspan="1" colspan="1">
<p><bold>Antibiotic</bold></p>
</td>
                <td rowspan="1" colspan="1">
<p><bold>Strain</bold></p>
</td>
                <td rowspan="1" colspan="1">
<p><bold>Mechanism of antibiotic resistance</bold></p>
</td>
                <td rowspan="1" colspan="1">
<p><bold>Detection of antibiotic resistance</bold></p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>Beta lactams<xref ref-type="bibr" rid="article-127216.r18">[18]</xref></p>
</td>
                <td rowspan="1" colspan="1">
<p><italic toggle="yes">E. faecium</italic></p>
</td>
                <td rowspan="1" colspan="1">
<p>An increased expression of penicillin-binding protein (PBP) 5-R type</p>
<p>Alterations in PBP5 protein around the active site<xref ref-type="bibr" rid="article-127216.r19">[19]</xref></p>
<p>Utilization of beta-lactam insensitive transpeptidase for cell wall synthesis<xref ref-type="bibr" rid="article-127216.r20">[20]</xref><xref ref-type="bibr" rid="article-127216.r21">[21]</xref><xref ref-type="bibr" rid="article-127216.r20">[20]</xref></p>
</td>
                <td rowspan="1" colspan="1">&#x000a0;</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">&#x000a0;</td>
                <td rowspan="1" colspan="1">
<p>E<italic toggle="yes">. faecalis</italic></p>
</td>
                <td rowspan="1" colspan="1">
<p>Amino acid changes in PBP-4<xref ref-type="bibr" rid="article-127216.r22">[22]</xref><xref ref-type="bibr" rid="article-127216.r23">[23]</xref></p>
<p>Plasmid-mediated beta-lactamases</p>
</td>
                <td rowspan="1" colspan="1">
<p>Nitrocefin test-rare penicillinase</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>Cephalosporins<xref ref-type="bibr" rid="article-127216.r24">[24]</xref></p>
</td>
                <td rowspan="1" colspan="1">
<p>All</p>
</td>
                <td rowspan="1" colspan="1">
<p>Intrinsic resistance, presence of serine-threonine kinase&#x000a0;</p>
</td>
                <td rowspan="1" colspan="1">&#x000a0;</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>Aminoglycosides, except for gentamicin and streptomycin</p>
</td>
                <td rowspan="1" colspan="1">
<p><italic toggle="yes">E. faecium</italic></p>
</td>
                <td rowspan="1" colspan="1">
<p>Tobramycin acetyltransferase&#x000a0;</p>
</td>
                <td rowspan="1" colspan="1">&#x000a0;</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">&#x000a0;</td>
                <td rowspan="1" colspan="1">
<p>All</p>
</td>
                <td rowspan="1" colspan="1">
<p><italic toggle="yes">aph(3')IIIa</italic> gene&#x000a0;</p>
</td>
                <td rowspan="1" colspan="1">&#x000a0;</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>Streptomycin<xref ref-type="bibr" rid="article-127216.r25">[25]</xref></p>
</td>
                <td rowspan="1" colspan="1">
<p>All</p>
</td>
                <td rowspan="1" colspan="1">
<p>Ribosomal mutation</p>
</td>
                <td rowspan="1" colspan="1">
<p>Brain heart infusion (BHI) agar with streptomycin</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>Gentamicin<xref ref-type="bibr" rid="article-127216.r26">[26]</xref></p>
</td>
                <td rowspan="1" colspan="1">
<p>All</p>
</td>
                <td rowspan="1" colspan="1">
<p><italic toggle="yes">aph(2")-Ia</italic> gene, which encodes a bifunctional enzyme with 2"-phosphotransferase and 6&#x02019;-acetyltransferase</p>
</td>
                <td rowspan="1" colspan="1">&#x000a0;</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>Clindamycin<xref ref-type="bibr" rid="article-127216.r27">[27]</xref></p>
</td>
                <td rowspan="1" colspan="1">
<p>All</p>
</td>
                <td rowspan="1" colspan="1">
<p><italic toggle="yes">lsa </italic>gene</p>
</td>
                <td rowspan="1" colspan="1">&#x000a0;</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>Vancomycin-low level</p>
</td>
                <td rowspan="1" colspan="1">
<p>All, especially <italic toggle="yes">E. gallinarum</italic> and <italic toggle="yes">E. cassesliflavus</italic></p>
</td>
                <td rowspan="1" colspan="1">
<p>Van C, E, G, L, N genes</p>
</td>
                <td rowspan="1" colspan="1">&#x000a0;</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>Vancomycin-high level:</p>
</td>
                <td rowspan="1" colspan="1">
<p>Especially&#x000a0;</p>
<p><italic toggle="yes">E. faecium</italic> and <italic toggle="yes">E. faecalis</italic></p>
</td>
                <td rowspan="1" colspan="1">
<p>Van A (most common), B, D, M.</p>
<p>They work by replacing the D-Ala-D-Ala terminus of peptidoglycan with D-Ala-D-lactate, which binds to vancomycin with significantly lower affinity. *</p>
</td>
                <td rowspan="1" colspan="1">
<p>BHI agar with vancomycin</p>
<p>Vancomycin susceptible: &#x0003c;/=4mcg/ml</p>
<p>Vancomycin intermediate: 8 to 16mcg/ml</p>
<p>Vancomycin-resistant: &#x0003e;/=32mcg/ml</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>Linezolid<xref ref-type="bibr" rid="article-127216.r28">[28]</xref></p>
</td>
                <td rowspan="1" colspan="1">
<p>All</p>
</td>
                <td rowspan="1" colspan="1">
<p>Mutation in 23S rRNA and other MGE resistances.</p>
</td>
                <td rowspan="1" colspan="1">&#x000a0;</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>Daptomycin<xref ref-type="bibr" rid="article-127216.r29">[29]</xref><xref ref-type="bibr" rid="article-127216.r30">[30]</xref><xref ref-type="bibr" rid="article-127216.r29">[29]</xref></p>
</td>
                <td rowspan="1" colspan="1">
<p>All</p>
</td>
                <td rowspan="1" colspan="1">
<p>Genetic mutations like cls, gdpD, and liaF impact the cell membranes' repulsion charge and target their composition.</p>
</td>
                <td rowspan="1" colspan="1">
<p>Muller Hinton broth with Ca ion concentration measurement</p>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>
<bold>&#x000a0;Table 1.&#x000a0;Mechanism of resistance to specific antibiotics</bold>
<xref ref-type="bibr" rid="article-127216.r31">[31]</xref>
<xref ref-type="bibr" rid="article-127216.r32">[32]</xref>
<xref ref-type="bibr" rid="article-127216.r33">[33]</xref>
</p>
        <p>*Sometimes, vancomycin-resistant genes are indolent, causing initial phenotypic vancomycin susceptibility that can later reverse in some emerging strains called vancomycin-variable enterococci (VVE).<xref ref-type="bibr" rid="article-127216.r34">[34]</xref>&#x000a0;Interestingly, studies also discovered vancomycin-dependent enterococci (VDE), which actually need vancomycin for growth, often after prolonged exposure to oral vancomycin regimens, rendering them difficult to isolate.<xref ref-type="bibr" rid="article-127216.r35">[35]</xref>&#x000a0;They are treated similarly to VRE. Enterococci are the main reason for vancomycin resistance in <italic toggle="yes">Staphylococcus aureus</italic> via horizontal VanA gene transfer when they co-exist.<xref ref-type="bibr" rid="article-127216.r36">[36]</xref></p>
      </sec>
      <sec id="article-127216.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>A thorough history must be obtained from patients, including a comprehensive fever history, antibiotic history including duration of antibiotic use, history of infection with multidrug-resistant organisms, history of previous hospitalizations or stays at skilled nursing facilities or nursing homes, appropriate cancer screening, HIV screening, past and recent surgical history, history of medical conditions like uncontrolled diabetes, recent cardiac valve replacement, nonhealing wounds and external lines like Mediport, Foley catheter, or peripherally inserted central lines (PICC). In addition, a physical examination of each organ system must be detailed, especially if the source of bacteremia is unknown.</p>
        <list list-type="bullet">
          <list-item>
            <p>Urinary tract infections (UTI) are the most common infections caused by enterococci, usually occurring in chronically ill patients in the nosocomial setting associated with obstruction, urinary catheterization, or instrumentation.<xref ref-type="bibr" rid="article-127216.r37">[37]</xref>&#x000a0;They can also cause complicated UTIs such as pyelonephritis, perinephric abscesses, and chronic prostatitis, which can all act as sources of bacteremia. Complicated UTIs are associated with diabetes mellitus,&#x000a0;pregnancy, indwelling urinary catheters and devices, immunocompromised state, neurogenic bladder,&#x000a0;urinary obstruction, and nephrolithiasis.</p>
          </list-item>
          <list-item>
            <p>Bacteremia is usually secondary to IV catheters, UTIs including catheter-associated urinary tract infections (CAUTI), intra-abdominal including biliary tract infections, wound infections including burns and ulcers, and bone infections.</p>
          </list-item>
          <list-item>
            <p>The prevalence of enterococcal infective endocarditis (IE) is consistently rising, present in 8 to 32% of enterococcal bacteremia cases, and it usually has a subacute course.<xref ref-type="bibr" rid="article-127216.r38">[38]</xref><xref ref-type="bibr" rid="article-127216.r39">[39]</xref>&#x000a0;Interestingly, enterococci was the most common pathogen causing IE in subjects who underwent transcatheter aortic valve implantation (TAVI), probably owing to their advanced age and comorbidities.<xref ref-type="bibr" rid="article-127216.r40">[40]</xref>&#x000a0;Infective endocarditis can present with a temperature &#x02265; 38 degrees C (100.4 degrees F),&#x000a0;Osler nodes,&#x000a0;Roth spots,&#x000a0;Janeway lesions, new heart murmur or worsening of preexisting murmur,&#x000a0;hematuria,&#x000a0;hematuria, and&#x000a0;splinter hemorrhages.</p>
          </list-item>
          <list-item>
            <p>Intra-abdominal collections and peritonitis are associated with enterococci as well.</p>
          </list-item>
          <list-item>
            <p>Meningitis is uncommon and is mainly associated with intraventricular shunts, neurosurgical procedures, CSF leakage, trauma, anatomical defects in CNS, and high-grade bacteremia in immunocompromised patients. Interestingly, some reports showed an association with <italic toggle="yes">Strongyloides</italic> hyperinfection.<xref ref-type="bibr" rid="article-127216.r41">[41]</xref><xref ref-type="bibr" rid="article-127216.r42">[42]</xref>&#x000a0;Patients can present with&#x000a0;altered mental status,&#x000a0;headache, neck stiffness,&#x000a0;fever,&#x000a0;lethargy, nausea, and vomiting.</p>
          </list-item>
          <list-item>
            <p>They are also sometimes seen in surgical-site infections, diabetic and decubitus ulcers, prosthetic joint infections, endophthalmitis, and dental and root canal failure infections.<xref ref-type="bibr" rid="article-127216.r43">[43]</xref></p>
          </list-item>
          <list-item>
            <p>Some outbreaks of neonatal enterococcal sepsis have been reported in the USA.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-127216.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Before antibiotic treatment is initiated, culture and gram stains from body fluids and blood must be obtained. Chest X-ray, echocardiogram, CT scan of the abdomen, or colonoscopy may be necessary per the infection's clinical context.</p>
        <list list-type="bullet">
          <list-item>
            <p>Enterococci are gram-positive, non-spore-forming cocci, usually appearing as short chains, diplococci, or single ovoid cells. They are facultative anaerobes that grow on culture media, tolerating a high 6.5% salt concentration and a wide range of temperatures. Although mostly non-hemolytic, some enterococci show alpha and beta hemolysis.<xref ref-type="bibr" rid="article-127216.r5">[5]</xref></p>
          </list-item>
          <list-item>
            <p>They are bench diagnosed as catalase-negative, urease-negative, Lancefield group D antigen-positive, esculin hydrolyzing in 40% bile salts, and PYR hydrolyzing, distinguishing it from <italic toggle="yes">Streptococcus gallolyticus.</italic>&#x000a0;Selective media and commercial kits use many of these properties for enterococci identification.&#x000a0;Intra-species differentiation is based on the fermentation of carbohydrates, hydrolysis of arginine, tolerance to tellurite, motility, and pigmentation.<xref ref-type="bibr" rid="article-127216.r44">[44]</xref></p>
          </list-item>
          <list-item>
            <p>Genetic methods have replaced traditional biochemical tests. They include gene probes, polymerase chain reaction (PCR), 16s rRNA sequencing, nucleic acid amplification testing (NAAT), matrix-assisted laser desorption ionization-time of flight (MALDI-TOF), and other new technologies.<xref ref-type="bibr" rid="article-127216.r45">[45]</xref><xref ref-type="bibr" rid="article-127216.r46">[46]</xref><xref ref-type="bibr" rid="article-127216.r47">[47]</xref><xref ref-type="bibr" rid="article-127216.r48">[48]</xref>&#x000a0;These can quickly identify enterococci among other microorganisms in a short time through species-specific protein segments and even detect their antimicrobial susceptibilities.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Enterococcus should be routinely tested for sensitivity to penicillin, vancomycin, and high-level aminoglycoside resistance (HLAR).<xref ref-type="bibr" rid="article-127216.r49">[49]</xref>&#x000a0;In the case of beta-lactam or vancomycin resistance, in vitro susceptibility to daptomycin and linezolid is warranted.</p>
          </list-item>
          <list-item>
            <p>The DENOVA tool can be used to predict endocarditis in patients with enterococcal bacteremia (based on the Duration of symptoms, Embolizations, Number of positive cultures, Origin, valve disease, and Auscultation murmurs). Some authors recommend transthoracic echocardiograms for all community-acquired and nosocomial enterococcal bacteremia.<xref ref-type="bibr" rid="article-127216.r39">[39]</xref><xref ref-type="bibr" rid="article-127216.r38">[38]</xref></p>
          </list-item>
          <list-item>
            <p>As a part of the evaluation, reports have proposed routine colonoscopies for cases of enterococcal bacteremia or IE of unclear source, given the high prevalence of new colonic neoplasms in this population, similar to the guidelines for <italic toggle="yes">Streptococcus bovis</italic> and <italic toggle="yes">Clostridium septicum.</italic><xref ref-type="bibr" rid="article-127216.r50">[50]</xref><xref ref-type="bibr" rid="article-127216.r51">[51]</xref><xref ref-type="bibr" rid="article-127216.r52">[52]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-127216.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The treatment of enterococcal infection depends on the type of infection and susceptibility of the organism to antibiotics.&#x000a0;Compared to&#x000a0;<italic toggle="yes">Enterococcus faecium</italic>, infections&#x000a0;due to&#x000a0;<italic toggle="yes">Enterococcus faecalis</italic>&#x000a0;tend to be more virulent, and bacteremia is&#x000a0;more likely to be associated with endocarditis. Even though penicillin and ampicillin inhibit enterococci, they are not often bactericidal. Vancomycin and aminoglycosides are also less bactericidal. Aminoglycoside has poor permeability, so it can be combined with a simultaneous cell-wall active agent to achieve the necessary intracellular&#x000a0;aminoglycoside concentration.<xref ref-type="bibr" rid="article-127216.r49">[49]</xref>&#x000a0;</p>
        <p>Penicillin or ampicillin are typically used to penetrate the cell wall with an aminoglycoside. Vancomycin combination with aminoglycoside increases the risk of nep[hrotoxicity. Therefore, vancomycin may only be used in cases of hypersensitivity with an inability to desensitize or in cases of high-level beta-lactam resistance.<xref ref-type="bibr" rid="article-127216.r53">[53]</xref>&#x000a0;<italic toggle="yes">E. faecalis</italic><italic toggle="yes">&#x000a0;</italic>is also more susceptible to ampicillin and more resistant to quinupristin-dalfopristin. The typically&#x000a0;recommended regimes for infections are described in the following table:</p>
        <table-wrap id="article-127216.table1" position="float" orientation="portrait">
          <table style="width: 700px;">
            <tbody>
              <tr style="height: 48px;">
                <td style="height: 48px; width: 70.3281px;" rowspan="1" colspan="1">
<p><bold>Disease</bold></p>
</td>
                <td style="height: 48px; width: 255.672px;" rowspan="1" colspan="1">
<p><bold>Sensitive strains</bold></p>
</td>
                <td style="height: 48px; width: 179px;" rowspan="1" colspan="1">
<p><bold>Ampicillin Resistant Enterococci</bold></p>
</td>
                <td style="height: 48px; width: 165px;" rowspan="1" colspan="1">
<p><bold>Ampicillin resistant + VRE (b)</bold></p>
</td>
              </tr>
              <tr style="height: 235px;">
                <td style="height: 235px; width: 70.3281px;" rowspan="1" colspan="1">
<p>UTI&#x000a0;</p>
</td>
                <td style="height: 235px; width: 255.672px;" rowspan="1" colspan="1">
<p>Simple UTI:</p>
<list list-type="bullet"><list-item><p>Nitrofurantoin&#x000a0;100 mg (monohydrate/macrocrystals) twice a day for 5 days</p></list-item><list-item><p>Amoxicillin for 500 mg orally 3 times a day for 5 days</p></list-item><list-item><p>Fosfomycin 3 g&#x000a0; as a single dose<xref ref-type="bibr" rid="article-127216.r54">[54]</xref></p></list-item></list>
<p>Complicated UTI:</p>
<list list-type="bullet"><list-item><p>Ampicillin 1 g IV every 6 hours for 5 days</p></list-item><list-item><p>Levofloxacin&#x000a0;750 mg IV or orally once a day</p></list-item></list>
</td>
                <td style="height: 235px; width: 179px;" rowspan="1" colspan="1">
<p>Used in cases of treatment failure on&#x000a0;previous agents:</p>
<list list-type="bullet"><list-item><p>Linezolid&#x000a0;600 mg orally or intravenously twice a day</p></list-item><list-item><p>Vancomycin: Starting&#x000a0;dose 15 mg/kg/dose IV every 12 hours, maximum 2 g per dose; monitor serum concentration for subsequent dosages.</p></list-item></list>
</td>
                <td style="height: 235px; width: 165px;" rowspan="1" colspan="1">
<p>Used in cases of treatment failure on&#x000a0;previous agents:</p>
<list list-type="bullet"><list-item><p>Linezolid 600 mg orally or intravenously twice a day</p></list-item><list-item><p>Daptomycin 8 mg/kg IV/day</p></list-item></list>
</td>
              </tr>
              <tr style="height: 148px;">
                <td style="height: 148px; width: 70.3281px;" rowspan="1" colspan="1">
<p>Bacteremia<xref ref-type="bibr" rid="article-127216.r55">[55]</xref></p>
</td>
                <td style="height: 148px; width: 255.672px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Ampicillin 1 to 2 g IV every 4 to 6 hours <bold>or</bold> penicillin 18 to 30 million units IV per 24 hours</p></list-item></list>
<p>May require the addition of either of these:</p>
<list list-type="bullet"><list-item><p>Ceftriaxone 2 g IV every 12 hours <bold>or</bold> gentamicin 1 mg/kg IV every 8 hours, <bold>or</bold> streptomycin 5 mg/kg IV or IM every 12 hours for 7-14 days</p></list-item></list>
</td>
                <td style="height: 148px; width: 179px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Vancomycin +/- aminoglycoside for 7-14 days (dosages as mentioned)</p></list-item><list-item><p>Ampicillin for 7-14 days&#x000a0;(dosages as mentioned)</p></list-item></list>
</td>
                <td style="height: 148px; width: 165px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Daptomycin for 7-14 days</p></list-item><list-item><p>Linezolid for 7-14 days</p></list-item></list>
</td>
              </tr>
              <tr style="height: 85px;">
                <td style="height: 85px; width: 70.3281px;" rowspan="1" colspan="1">
<p>Infective endocarditis</p>
<p>(a)</p>
</td>
                <td style="height: 85px; width: 255.672px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Ampicillin + ceftriaxone&#x000a0;for 6 weeks&#x000a0;(dosages as mentioned)</p></list-item><list-item><p>Ampicillin/penicillin + aminoglycoside for 4-6 weeks&#x000a0;(dosages as mentioned)</p></list-item></list>
</td>
                <td style="height: 85px; width: 179px;" rowspan="1" colspan="1">
<p>Vancomycin&#x000a0;+ aminoglycoside for 6 weeks&#x000a0;(dosages as mentioned)</p>
</td>
                <td style="height: 85px; width: 165px;" rowspan="1" colspan="1">
<p>Daptomycin&#x000a0;8 to 12 mg/kg every 24 hours <bold>and</bold>&#x000a0;ampicillin/ceftaroline for 6-8 weeks</p>
<p>Linezolid for 6-8 weeks&#x000a0;(dosages as mentioned)</p>
</td>
              </tr>
              <tr style="height: 74px;">
                <td style="height: 74px; width: 70.3281px;" rowspan="1" colspan="1">
<p>Intra-abdominal</p>
</td>
                <td style="height: 74px; width: 255.672px;" rowspan="1" colspan="1">
<p>It is not recommended to empirically cover enterococcus unless identified in persistent collections, peritonitis, immunocompromised, or severely septic patients.</p>
</td>
              </tr>
              <tr style="height: 85px;">
                <td style="height: 85px; width: 70.3281px;" rowspan="1" colspan="1">
<p>Meningitis<xref ref-type="bibr" rid="article-127216.r56">[56]</xref></p>
</td>
                <td style="height: 85px; width: 255.672px;" rowspan="1" colspan="1">
<p>Ampicillin +&#x000a0;ceftriaxone + aminoglycoside&#x000a0;for 10-14 days&#x000a0;(dosages as mentioned)</p>
</td>
                <td style="height: 85px; width: 179px;" rowspan="1" colspan="1">
<p>Vancomycin + aminoglycoside for 10-14 days (can add intrathecally)&#x000a0;(dosages as mentioned)</p>
</td>
                <td style="height: 85px; width: 165px;" rowspan="1" colspan="1">
<p>Linezolid IV for 10-14 days&#x000a0;(dosages as mentioned)</p>
<p>Daptomycin (IV+intrathecal) +/- aminoglycoside&#x000a0;(dosages as mentioned)</p>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>
<bold>Table 2. Routine recommended antibiotics regimens and duration for common enterococcal infections</bold>
</p>
        <p>(a) Given the bacteriostatic effect of beta-lactams on enterococci at the usual doses, combination therapy with a beta-lactam (usually ampicillin) plus an aminoglycoside (specifically gentamicin or streptomycin) for 4 to 6 weeks has been the standard to achieve bacteriocidal action against enterococci in cases of IE. This prolonged use of aminoglycosides often causes nephrotoxicity and ototoxicity, as highlighted in the old paper &#x0201c;Deaf or Dead&#x0201d; Most recently, a two beta-lactam combination with ampicillin and ceftriaxone for six weeks duration has shown to be an equal alternative, with less toxicity leading to less interruption, and an effective option for HLAR isolates.<xref ref-type="bibr" rid="article-127216.r57">[57]</xref><xref ref-type="bibr" rid="article-127216.r58">[58]</xref><xref ref-type="bibr" rid="article-127216.r59">[59]</xref><xref ref-type="bibr" rid="article-127216.r60">[60]</xref><xref ref-type="bibr" rid="article-127216.r61">[61]</xref><xref ref-type="bibr" rid="article-127216.r62">[62]</xref><xref ref-type="bibr" rid="article-127216.r63">[63]</xref><xref ref-type="bibr" rid="article-127216.r18">[18]</xref>&#x000a0;However, it is level B evidence, not definitive, and holds more for <italic toggle="yes">E. faecalis</italic> than <italic toggle="yes">E. faecium.</italic><xref ref-type="bibr" rid="article-127216.r64">[64]</xref><xref ref-type="bibr" rid="article-127216.r65">[65]</xref>&#x000a0;</p>
        <p>(b) VRE treatment options are outlined below:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Linezolid is the only FDA-approved agent for VRE. It has also been studied in combination with gentamicin, doxycycline, or rifampicin.<xref ref-type="bibr" rid="article-127216.r66">[66]</xref></p>
          </list-item>
          <list-item>
            <p>Daptomycin has been used alone or in combination with ceftaroline, ampicillin, ertapenem, tigecycline, and fosfomycin. For high MICs, a high dose of &#x0003e; 6 mg/kg/day is used.<xref ref-type="bibr" rid="article-127216.r67">[67]</xref></p>
          </list-item>
          <list-item>
            <p>Quinupristin/dalfopristin was used against <italic toggle="yes">E. faecium</italic> only but was subsequently withdrawn from the market for causing phlebitis and myalgias.</p>
          </list-item>
          <list-item>
            <p>Oritavancin<xref ref-type="bibr" rid="article-127216.r66">[66]</xref></p>
          </list-item>
          <list-item>
            <p>Most recently, tedizolid was shown to be efficacious, but robust clinical data is still lacking.<xref ref-type="bibr" rid="article-127216.r66">[66]</xref></p>
          </list-item>
          <list-item>
            <p>Tigecycline is the last salvage treatment for VRE.</p>
          </list-item>
        </list>
        <p>There have been several studies comparing linezolid and daptomycin for VRE bacteremia and endocarditis, with mixed results. However, linezolid and high-dose daptomycin are both equally more effective than low-dose daptomycin.<xref ref-type="bibr" rid="article-127216.r67">[67]</xref><xref ref-type="bibr" rid="article-127216.r68">[68]</xref></p>
        <p>
<bold>Newer Therapies</bold>
</p>
        <p>Commensal probiotic cocktails are suggested to prevent and reverse gut colonization with VRE. They mainly contain four species; <italic toggle="yes">Clostridium bolteae</italic>, <italic toggle="yes">Parabacteroides distasonis</italic>, <italic toggle="yes">Bacteroides sartorii</italic>, and <italic toggle="yes">Blautia producta</italic>, which secretes a lantibiotic that is highly effective against VRE.<xref ref-type="bibr" rid="article-127216.r69">[69]</xref></p>
        <p>Methods to significantly limit enterococcal adherence with its related infections and biofilm formation include:</p>
        <p>a) Use of surface coatings with specific antimicrobial and antiadhesive properties on catheters and implants like non-leachable cationic film coatings.<xref ref-type="bibr" rid="article-127216.r17">[17]</xref></p>
        <p>b) Vaccination or antibody therapy directed against the enterococcal pilus tip EbpA.<xref ref-type="bibr" rid="article-127216.r17">[17]</xref></p>
        <p>Propionate, one of the short-chain fatty acids (SCFA), has shown antimicrobial effects on enterococci in the mouth to treat dental plaques and infections.<xref ref-type="bibr" rid="article-127216.r70">[70]</xref>&#x000a0;Highly specific lytic bacteriophage therapy has shown to be rapidly efficacious when used against enterococcal infections, both <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo</italic>, with one study even on humans with chronic prostatitis.<xref ref-type="bibr" rid="article-127216.r71">[71]</xref><xref ref-type="bibr" rid="article-127216.r72">[72]</xref>&#x000a0;</p>
        <p>Phage therapy has also been shown to induce anti-phage modifications in the enterococcal cell wall, rendering them less capable of intestinal colonization, expansion, or antibiotic resistance.<xref ref-type="bibr" rid="article-127216.r73">[73]</xref>&#x000a0;Phage endolysins can be used successfully against resistant enterococci without actual phage therapy, per several studies.<xref ref-type="bibr" rid="article-127216.r71">[71]</xref>&#x000a0;CRISPR gene activating modalities have been proposed to limit horizontal antibiotic resistance gene transfer among enterococci.<xref ref-type="bibr" rid="article-127216.r74">[74]</xref>&#x000a0;</p>
        <p>An idea exists for developing monoclonal antibodies targeting enterococcal signal transduction pathways to interfere with the antibiotic resistance gene.<xref ref-type="bibr" rid="article-127216.r36">[36]</xref></p>
      </sec>
      <sec id="article-127216.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Preliminary culture data from urine, blood, cerebrospinal fluid, tissue, fluid, or wounds are generally read as Gram-positive cocci in chains. Differentials at this point can include Group A, B, and C Streptococci, and&#x000a0;<italic toggle="yes">Streptococcus bovis</italic>, in addition to enterococcal species. However, when a nosocomial infection is likely in a critically ill patient, one should empirically cover for Enterococcus before the final culture read is available.</p>
        <p>UTI, bacteremia, infective endocarditis, meningitis, intra-abdominal, and wound infections can be caused by hundreds of pathogens that can mimic an enterococcal infection. Again, if suspicion of resistant species exists in the appropriate clinic context, empiric broad-spectrum antibiotic coverage is warranted until sensitivities can be obtained.</p>
      </sec>
      <sec id="article-127216.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>In systematic reviews, VRE infections have demonstrated a two-fold increase in morbidity, mortality, and economic burden compared to vancomycin-sensitive isolates, even after VRE treatments were made available.<xref ref-type="bibr" rid="article-127216.r75">[75]</xref>&#x000a0;VRE infections also increased the overall length of hospital stay, LTC facility discharges, and readmissions.<xref ref-type="bibr" rid="article-127216.r13">[13]</xref></p>
        <p>Enterococcal endocarditis has a mortality rate of 11&#x000a0;to 35%, while the mortality rate for enterococcal bacteremia is 25%, and for enterococcal meningitis is 20%.<xref ref-type="bibr" rid="article-127216.r1">[1]</xref></p>
      </sec>
      <sec id="article-127216.s11" sec-type="Complications">
        <title>Complications</title>
        <p>A study suggested an a<italic toggle="yes">sso</italic>ciation between <italic toggle="yes">E. gallinarum</italic> gut translocation and autoantibodies production, as seen in inflammatory bowel disease.<xref ref-type="bibr" rid="article-127216.r5">[5]</xref>&#x000a0;</p>
        <p>Extracellular superoxide produced by<italic toggle="yes"> E. faecalis</italic> causes DNA instability and inflammatory changes in the colonic mucosa, leading to colorectal cancer.<xref ref-type="bibr" rid="article-127216.r1">[1]</xref>&#x000a0;This finding was supported by a higher burden of<italic toggle="yes"> E. faecalis</italic> in the stools of colon cancer patients than in controls.&#x000a0;</p>
        <p>Enterococcal cytolysin causes liver cell injury, especially in patients with alcoholic hepatitis, correlating with both-disease severity and mortality. Hence one of the therapies suggested for this patient population is cytolytic enterococci-specific bacteriophages.<xref ref-type="bibr" rid="article-127216.r76">[76]</xref></p>
        <p>Fecal enterococci abundance has been associated with high graft versus host disease (GVHD) in the allogeneic hematopoietic transplant patients population. Interestingly, the predominance of enterococci over regular clostridia species in the gut of patients with GVHD was associated with diets with higher lactose intake. Hence lactose-free diet or lactase-based therapy is suggested for these patients to prevent the overgrowth of enterococci.<xref ref-type="bibr" rid="article-127216.r77">[77]</xref><xref ref-type="bibr" rid="article-127216.r78">[78]</xref></p>
        <p><italic toggle="yes">E. faecalis</italic> and&#x000a0;<italic toggle="yes">E. faecium</italic> strains have been utilized as human probiotics in common preparations for diarrhea, irritable bowel syndrome, hypercholesterolemia, and immunity boosters. They have also been used in animals to promote growth and as starters for fermenting food. So far, no infections or safety concerns of these specific probiotics have been reported. However, they need to be monitored closely for the potential development of problematic lineages from old or new strains.<xref ref-type="bibr" rid="article-127216.r79">[79]</xref><xref ref-type="bibr" rid="article-127216.r80">[80]</xref></p>
      </sec>
      <sec id="article-127216.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients must be educated to practice good hand hygiene, keep the catheter sites clean, monitor for erythema around those sites, and alert their doctors if they feel ill or have spiking fevers. Patients should also be aware of the duration that catheters and prosthetic devices have been in place and make sure providers note them down, too.</p>
      </sec>
      <sec id="article-127216.s13" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <list list-type="order">
          <list-item>
            <p>Enterococci are Gram-positive facultative anaerobic cocci in short and medium chains commonly associated with nosocomial infections.</p>
          </list-item>
          <list-item>
            <p>VRE is seen in patients with prolonged hospitalization, ICU stays, residence in long-term care (LTC) facilities, hemodialysis patients, and diabetes, cancer, and transplant patients.</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">E. faecium</italic>&#x000a0;species are 80% vancomycin-resistant and 90% ampicillin-resistant compared to <italic toggle="yes">E. faecalis</italic> species, which are only 10% vancomycin-resistant and mostly ampicillin sensitive.</p>
          </list-item>
          <list-item>
            <p>Virulence factors include structural durability, bacteriocins, hemolysin/cytolysin, gelatinase, serine protease, and biofilm production. Antibiotic resistance is intrinsic or acquired through the transfer of resistance-related mobile genetic elements (MGE) via various mechanisms like plasmids, conjugation, and transposons.</p>
          </list-item>
          <list-item>
            <p>Vancomycin resistance is attributed to the vanA gene, which replaces the D-Ala-D-Ala terminus of peptidoglycan with D-Ala-D-lactate, which binds to vancomycin with significantly lower affinity. VanA gene confers vancomycin resistance to MRSA via horizontal transmission.</p>
          </list-item>
          <list-item>
            <p>Enterococci can cause UTIs, bacteremia, IE, meningitis, intra-abdominal infections, and wound infections. Resistant strains require prolonged courses of antibiotics.</p>
          </list-item>
          <list-item>
            <p>Enterococcus should be routinely tested for sensitivity to penicillin, vancomycin, and high-level aminoglycoside resistance (HLAR). In the case of beta-lactam or vancomycin resistance, i<italic toggle="yes">n vitro</italic> susceptibility to daptomycin and linezolid is warranted.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Hand hygiene is paramount to preventing patient-to-patient transmission of VRE. Surveillance stool cultures may be required in high-risk patients in ICUs, transplant patients, and LTC patients to prevent the colonization of the GI tract and subsequent infections.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-127216.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The Infectious Disease team, Infection Prevention Committee, and Antimicrobial Stewardship Program are crucial in tackling enterococcus and VRE&#x000a0;infections and implementing preventive measures to limit hospital-related outbreaks. Clinicians, nurses, and pharmacists form an important interprofessional team to treat enterococcal infections.<xref ref-type="bibr" rid="article-127216.r9">[9]</xref><xref ref-type="bibr" rid="article-127216.r81">[81]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>The CDC recommends prompt active screening via rectal and perirectal swabs or stool samples, with subsequent reporting of VRE in high-risk patients such as those in the ICU, transplant or oncology wards, hemodialysis or immunocompromised patients, prolonged hospitalizations, and admissions from LTC, as it has shown to be cost-effective for preventing colonization, infections, and deaths.<xref ref-type="bibr" rid="article-127216.r82">[82]</xref><xref ref-type="bibr" rid="article-127216.r83">[83]</xref><xref ref-type="bibr" rid="article-127216.r84">[84]</xref></p>
          </list-item>
          <list-item>
            <p>Specific environmental cleaning modalities, such as the non-touch automated mobile ultraviolet units and routine chlorhexidine bathing, especially in the ICU, are recommended for reducing the VRE burden.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>HCW training on hand hygiene is associated with a 47% decline in acquiring VRE in hospitals.<xref ref-type="bibr" rid="article-127216.r9">[9]</xref><xref ref-type="bibr" rid="article-127216.r85">[85]</xref></p>
          </list-item>
          <list-item>
            <p>Contact isolation for VRE patients is used in most hospitals; however, there is no consistent data to support it.<xref ref-type="bibr" rid="article-127216.r86">[86]</xref><xref ref-type="bibr" rid="article-127216.r87">[87]</xref></p>
          </list-item>
          <list-item>
            <p>Antibiotic stewardship programs that limit the use of cephalosporins, antibiotics against anaerobes, vancomycin, and broad-spectrum antibiotics, play an essential role in preventing the emergence and spread of this pathogen.<xref ref-type="bibr" rid="article-127216.r9">[9]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-127216.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=127216&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=127216">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/enterococcus-infections/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=127216">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/127216/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=127216">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-127216.s16">
        <title>References</title>
        <ref id="article-127216.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fiore</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Van Tyne</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gilmore</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>Pathogenicity of Enterococci.</article-title>
            <source>Microbiol Spectr</source>
            <year>2019</year>
            <month>Jul</month>
            <volume>7</volume>
            <issue>4</issue>
            <pub-id pub-id-type="pmid">31298205</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhen</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Lundborg</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Dong</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Economic burden of antibiotic resistance in ESKAPE organisms: a systematic review.</article-title>
            <source>Antimicrob Resist Infect Control</source>
            <year>2019</year>
            <volume>8</volume>
            <fpage>137</fpage>
            <pub-id pub-id-type="pmid">31417673</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Raza</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ullah</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Mehmood</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Andleeb</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Vancomycin resistant Enterococci: A brief review.</article-title>
            <source>J Pak Med Assoc</source>
            <year>2018</year>
            <month>May</month>
            <volume>68</volume>
            <issue>5</issue>
            <fpage>768</fpage>
            <page-range>768-772</page-range>
            <pub-id pub-id-type="pmid">29885179</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miller</surname>
                <given-names>WR</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>BE</given-names>
              </name>
              <name>
                <surname>Rice</surname>
                <given-names>LB</given-names>
              </name>
              <name>
                <surname>Arias</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>Vancomycin-Resistant Enterococci: Therapeutic Challenges in the 21st Century.</article-title>
            <source>Infect Dis Clin North Am</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>30</volume>
            <issue>2</issue>
            <fpage>415</fpage>
            <page-range>415-439</page-range>
            <pub-id pub-id-type="pmid">27208766</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garc&#x000ed;a-Solache</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rice</surname>
                <given-names>LB</given-names>
              </name>
            </person-group>
            <article-title>The Enterococcus: a Model of Adaptability to Its Environment.</article-title>
            <source>Clin Microbiol Rev</source>
            <year>2019</year>
            <month>Mar</month>
            <day>20</day>
            <volume>32</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">30700430</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Monticelli</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Knezevich</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Luzzati</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Di Bella</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Clinical management of non-faecium non-faecalis vancomycin-resistant enterococci infection. Focus on Enterococcus gallinarum and&#x000a0;Enterococcus casseliflavus/flavescens.</article-title>
            <source>J Infect Chemother</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>24</volume>
            <issue>4</issue>
            <fpage>237</fpage>
            <page-range>237-246</page-range>
            <pub-id pub-id-type="pmid">29396199</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pinkes</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>CS</given-names>
              </name>
            </person-group>
            <article-title>Native-valve Enterococcus hirae endocarditis: a case report and review of the literature.</article-title>
            <source>BMC Infect Dis</source>
            <year>2019</year>
            <month>Oct</month>
            <day>24</day>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>891</fpage>
            <pub-id pub-id-type="pmid">31651255</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mastroianni</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Enterococcus raffinosus endocarditis. First case and literature review.</article-title>
            <source>Infez Med</source>
            <year>2009</year>
            <month>Mar</month>
            <volume>17</volume>
            <issue>1</issue>
            <fpage>14</fpage>
            <page-range>14-20</page-range>
            <pub-id pub-id-type="pmid">19359819</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reyes</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bardossy</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Zervos</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Vancomycin-Resistant Enterococci: Epidemiology, Infection Prevention, and Control.</article-title>
            <source>Infect Dis Clin North Am</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>30</volume>
            <issue>4</issue>
            <fpage>953</fpage>
            <page-range>953-965</page-range>
            <pub-id pub-id-type="pmid">27660091</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fern&#x000e1;ndez-Hidalgo</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Escol&#x000e0;-Verg&#x000e9;</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Enterococcus faecalis Bacteremia: Consider an Echocardiography, But Consult an Infectious&#x000a0;Diseases Specialist.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2019</year>
            <month>Jul</month>
            <day>16</day>
            <volume>74</volume>
            <issue>2</issue>
            <fpage>202</fpage>
            <page-range>202-204</page-range>
            <pub-id pub-id-type="pmid">31296292</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ostrowsky</surname>
                <given-names>BE</given-names>
              </name>
              <name>
                <surname>Trick</surname>
                <given-names>WE</given-names>
              </name>
              <name>
                <surname>Sohn</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Quirk</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Holt</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Carson</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Hill</surname>
                <given-names>BC</given-names>
              </name>
              <name>
                <surname>Arduino</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Kuehnert</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Jarvis</surname>
                <given-names>WR</given-names>
              </name>
            </person-group>
            <article-title>Control of vancomycin-resistant enterococcus in health care facilities in a region.</article-title>
            <source>N Engl J Med</source>
            <year>2001</year>
            <month>May</month>
            <day>10</day>
            <volume>344</volume>
            <issue>19</issue>
            <fpage>1427</fpage>
            <page-range>1427-33</page-range>
            <pub-id pub-id-type="pmid">11346807</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chanderraj</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Millar</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>TS</given-names>
              </name>
              <name>
                <surname>Read</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Washer</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Kaye</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Woods</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>Vancomycin-Resistant <italic>Enterococcus</italic> Acquisition in a Tertiary Care Hospital: Testing the Roles of Antibiotic Use, Proton Pump Inhibitor Use, and Colonization Pressure.</article-title>
            <source>Open Forum Infect Dis</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>6</volume>
            <issue>4</issue>
            <fpage>ofz139</fpage>
            <pub-id pub-id-type="pmid">31024976</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chiang</surname>
                <given-names>HY</given-names>
              </name>
              <name>
                <surname>Perencevich</surname>
                <given-names>EN</given-names>
              </name>
              <name>
                <surname>Nair</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Samore</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Khader</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Chorazy</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Herwaldt</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Blevins</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ward</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Schweizer</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Incidence and Outcomes Associated With Infections Caused by Vancomycin-Resistant Enterococci in the United States: Systematic Literature Review and Meta-Analysis.</article-title>
            <source>Infect Control Hosp Epidemiol</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>38</volume>
            <issue>2</issue>
            <fpage>203</fpage>
            <page-range>203-215</page-range>
            <pub-id pub-id-type="pmid">27825401</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gross</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Harkavy</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Barden</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Flower</surname>
                <given-names>MF</given-names>
              </name>
            </person-group>
            <article-title>The epidemiology of nosocomial enterococcal urinary tract infection.</article-title>
            <source>Am J Med Sci</source>
            <year>1976</year>
            <season>Jul-Aug</season>
            <volume>272</volume>
            <issue>1</issue>
            <fpage>75</fpage>
            <page-range>75-81</page-range>
            <pub-id pub-id-type="pmid">822713</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mikulska</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Del Bono</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Raiola</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Bruno</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Gualandi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Occhini</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>di Grazia</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Frassoni</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bacigalupo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Viscoli</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of Gram-negative rods and increasing antibiotic resistance.</article-title>
            <source>Biol Blood Marrow Transplant</source>
            <year>2009</year>
            <month>Jan</month>
            <volume>15</volume>
            <issue>1</issue>
            <fpage>47</fpage>
            <page-range>47-53</page-range>
            <pub-id pub-id-type="pmid">19135942</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bedini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Codeluppi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cocchi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Guaraldi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Di Benedetto</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Venturelli</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Masetti</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Prati</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Mussini</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Borghi</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Girardis</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gerunda</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Rumpianesi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Esposito</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Gram-positive bloodstream infections in liver transplant recipients: incidence, risk factors, and impact on survival.</article-title>
            <source>Transplant Proc</source>
            <year>2007</year>
            <season>Jul-Aug</season>
            <volume>39</volume>
            <issue>6</issue>
            <fpage>1947</fpage>
            <page-range>1947-9</page-range>
            <pub-id pub-id-type="pmid">17692662</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ch'ng</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Chong</surname>
                <given-names>KKL</given-names>
              </name>
              <name>
                <surname>Lam</surname>
                <given-names>LN</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Kline</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>Biofilm-associated infection by enterococci.</article-title>
            <source>Nat Rev Microbiol</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>17</volume>
            <issue>2</issue>
            <fpage>82</fpage>
            <page-range>82-94</page-range>
            <pub-id pub-id-type="pmid">30337708</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gagetti</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bonofiglio</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a Gabarrot</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kaufman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mollerach</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vigliarolo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>von Specht</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Toresani</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Lopardo</surname>
                <given-names>HA</given-names>
              </name>
            </person-group>
            <article-title>Resistance to &#x003b2;-lactams in enterococci.</article-title>
            <source>Rev Argent Microbiol</source>
            <year>2019</year>
            <season>Apr-Jun</season>
            <volume>51</volume>
            <issue>2</issue>
            <fpage>179</fpage>
            <page-range>179-183</page-range>
            <pub-id pub-id-type="pmid">30243525</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rice</surname>
                <given-names>LB</given-names>
              </name>
              <name>
                <surname>Bellais</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Carias</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Hutton-Thomas</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bonomo</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Caspers</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Page</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Gutmann</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Impact of specific pbp5 mutations on expression of beta-lactam resistance in Enterococcus faecium.</article-title>
            <source>Antimicrob Agents Chemother</source>
            <year>2004</year>
            <month>Aug</month>
            <volume>48</volume>
            <issue>8</issue>
            <fpage>3028</fpage>
            <page-range>3028-32</page-range>
            <pub-id pub-id-type="pmid">15273117</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mainardi</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Legrand</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Arthur</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schoot</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>van Heijenoort</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gutmann</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Novel mechanism of beta-lactam resistance due to bypass of DD-transpeptidation in Enterococcus faecium.</article-title>
            <source>J Biol Chem</source>
            <year>2000</year>
            <month>Jun</month>
            <day>02</day>
            <volume>275</volume>
            <issue>22</issue>
            <fpage>16490</fpage>
            <page-range>16490-6</page-range>
            <pub-id pub-id-type="pmid">10748168</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mainardi</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Morel</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Fourgeaud</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cremniter</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Blanot</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Legrand</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Frehel</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Arthur</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Van Heijenoort</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gutmann</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Balance between two transpeptidation mechanisms determines the expression of beta-lactam resistance in Enterococcus faecium.</article-title>
            <source>J Biol Chem</source>
            <year>2002</year>
            <month>Sep</month>
            <day>27</day>
            <volume>277</volume>
            <issue>39</issue>
            <fpage>35801</fpage>
            <page-range>35801-7</page-range>
            <pub-id pub-id-type="pmid">12077139</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Concei&#x000e7;&#x000e3;o</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>da Silva</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Darini</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Pitondo-Silva</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>de Oliveira</surname>
                <given-names>AG</given-names>
              </name>
            </person-group>
            <article-title>Penicillin-resistant, ampicillin-susceptible Enterococcus faecalis of hospital origin: pbp4 gene polymorphism and genetic diversity.</article-title>
            <source>Infect Genet Evol</source>
            <year>2014</year>
            <month>Dec</month>
            <volume>28</volume>
            <fpage>289</fpage>
            <page-range>289-95</page-range>
            <pub-id pub-id-type="pmid">25445645</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Infante</surname>
                <given-names>VH</given-names>
              </name>
              <name>
                <surname>Concei&#x000e7;&#x000e3;o</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>de Oliveira</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Darini</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of polymorphisms in pbp4 gene and genetic diversity in penicillin-resistant, ampicillin-susceptible Enterococcus faecalis from hospitals in different states in Brazil.</article-title>
            <source>FEMS Microbiol Lett</source>
            <year>2016</year>
            <month>Apr</month>
            <volume>363</volume>
            <issue>7</issue>
            <pub-id pub-id-type="pmid">26903013</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Desbonnet</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tait-Kamradt</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Garcia-Solache</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dunman</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Coleman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Arthur</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rice</surname>
                <given-names>LB</given-names>
              </name>
            </person-group>
            <article-title>Involvement of the Eukaryote-Like Kinase-Phosphatase System and a Protein That Interacts with Penicillin-Binding Protein 5 in Emergence of Cephalosporin Resistance in Cephalosporin-Sensitive Class A Penicillin-Binding Protein Mutants in Enterococcus faecium.</article-title>
            <source>mBio</source>
            <year>2016</year>
            <month>Apr</month>
            <day>05</day>
            <volume>7</volume>
            <issue>2</issue>
            <fpage>e02188</fpage>
            <page-range>e02188-15</page-range>
            <pub-id pub-id-type="pmid">27048803</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eliopoulos</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Farber</surname>
                <given-names>BF</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>BE</given-names>
              </name>
              <name>
                <surname>Wennersten</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Moellering</surname>
                <given-names>RC</given-names>
              </name>
            </person-group>
            <article-title>Ribosomal resistance of clinical enterococcal to streptomycin isolates.</article-title>
            <source>Antimicrob Agents Chemother</source>
            <year>1984</year>
            <month>Mar</month>
            <volume>25</volume>
            <issue>3</issue>
            <fpage>398</fpage>
            <page-range>398-9</page-range>
            <pub-id pub-id-type="pmid">6326668</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mederski-Samoraj</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>BE</given-names>
              </name>
            </person-group>
            <article-title>High-level resistance to gentamicin in clinical isolates of enterococci.</article-title>
            <source>J Infect Dis</source>
            <year>1983</year>
            <month>Apr</month>
            <volume>147</volume>
            <issue>4</issue>
            <fpage>751</fpage>
            <page-range>751-7</page-range>
            <pub-id pub-id-type="pmid">6404994</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Singh</surname>
                <given-names>KV</given-names>
              </name>
              <name>
                <surname>Weinstock</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>BE</given-names>
              </name>
            </person-group>
            <article-title>An Enterococcus faecalis ABC homologue (Lsa) is required for the resistance of this species to clindamycin and quinupristin-dalfopristin.</article-title>
            <source>Antimicrob Agents Chemother</source>
            <year>2002</year>
            <month>Jun</month>
            <volume>46</volume>
            <issue>6</issue>
            <fpage>1845</fpage>
            <page-range>1845-50</page-range>
            <pub-id pub-id-type="pmid">12019099</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shinabarger</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Marotti</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Melchior</surname>
                <given-names>EP</given-names>
              </name>
              <name>
                <surname>Swaney</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Dunyak</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Demyan</surname>
                <given-names>WF</given-names>
              </name>
              <name>
                <surname>Buysse</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Mechanism of action of oxazolidinones: effects of linezolid and eperezolid on translation reactions.</article-title>
            <source>Antimicrob Agents Chemother</source>
            <year>1997</year>
            <month>Oct</month>
            <volume>41</volume>
            <issue>10</issue>
            <fpage>2132</fpage>
            <page-range>2132-6</page-range>
            <pub-id pub-id-type="pmid">9333037</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tran</surname>
                <given-names>TT</given-names>
              </name>
              <name>
                <surname>Munita</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Arias</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>Mechanisms of drug resistance: daptomycin resistance.</article-title>
            <source>Ann N Y Acad Sci</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>1354</volume>
            <fpage>32</fpage>
            <page-range>32-53</page-range>
            <pub-id pub-id-type="pmid">26495887</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tran</surname>
                <given-names>TT</given-names>
              </name>
              <name>
                <surname>Panesso</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mishra</surname>
                <given-names>NN</given-names>
              </name>
              <name>
                <surname>Mileykovskaya</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Guan</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Munita</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Reyes</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Diaz</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Weinstock</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>BE</given-names>
              </name>
              <name>
                <surname>Shamoo</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Dowhan</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Bayer</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Arias</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>Daptomycin-resistant Enterococcus faecalis diverts the antibiotic molecule from the division septum and remodels cell membrane phospholipids.</article-title>
            <source>mBio</source>
            <year>2013</year>
            <month>Jul</month>
            <day>23</day>
            <volume>4</volume>
            <issue>4</issue>
            <pub-id pub-id-type="pmid">23882013</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arthur</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Courvalin</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Genetics and mechanisms of glycopeptide resistance in enterococci.</article-title>
            <source>Antimicrob Agents Chemother</source>
            <year>1993</year>
            <month>Aug</month>
            <volume>37</volume>
            <issue>8</issue>
            <fpage>1563</fpage>
            <page-range>1563-71</page-range>
            <pub-id pub-id-type="pmid">8215264</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mendes</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Deshpande</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Castanheira</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>DiPersio</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Saubolle</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>RN</given-names>
              </name>
            </person-group>
            <article-title>First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States.</article-title>
            <source>Antimicrob Agents Chemother</source>
            <year>2008</year>
            <month>Jun</month>
            <volume>52</volume>
            <issue>6</issue>
            <fpage>2244</fpage>
            <page-range>2244-6</page-range>
            <pub-id pub-id-type="pmid">18391032</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sadowy</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Linezolid resistance genes and genetic elements enhancing their dissemination in enterococci and streptococci.</article-title>
            <source>Plasmid</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>99</volume>
            <fpage>89</fpage>
            <page-range>89-98</page-range>
            <pub-id pub-id-type="pmid">30253132</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Downing</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Xiong</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Eshaghi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>McGeer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Johnstone</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Vancomycin-Variable Enterococcal Bacteremia.</article-title>
            <source>J Clin Microbiol</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>53</volume>
            <issue>12</issue>
            <fpage>3951</fpage>
            <page-range>3951-3</page-range>
            <pub-id pub-id-type="pmid">26424845</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sukumaran</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Cosh</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Thammavong</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kennedy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ong</surname>
                <given-names>CW</given-names>
              </name>
            </person-group>
            <article-title>Vancomycin dependent Enterococcus: an unusual mutant?</article-title>
            <source>Pathology</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>51</volume>
            <issue>3</issue>
            <fpage>318</fpage>
            <page-range>318-320</page-range>
            <pub-id pub-id-type="pmid">30846227</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miller</surname>
                <given-names>WR</given-names>
              </name>
              <name>
                <surname>Munita</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Arias</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>Mechanisms of antibiotic resistance in enterococci.</article-title>
            <source>Expert Rev Anti Infect Ther</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>12</volume>
            <issue>10</issue>
            <fpage>1221</fpage>
            <page-range>1221-36</page-range>
            <pub-id pub-id-type="pmid">25199988</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <collab>NNIS System</collab>
            <article-title>National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1990-May 1999, issued June 1999. A report from the NNIS System.</article-title>
            <source>Am J Infect Control</source>
            <year>1999</year>
            <month>Dec</month>
            <volume>27</volume>
            <issue>6</issue>
            <fpage>520</fpage>
            <page-range>520-32</page-range>
            <pub-id pub-id-type="pmid">10586157</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dahl</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Iversen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tonder</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hoest</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Arpi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dalsgaard</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chehri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Soerensen</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Fanoe</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Junge</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hoest</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Valeur</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Lauridsen</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>Fosbol</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hoi-Hansen</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bruun</surname>
                <given-names>NE</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of Infective Endocarditis in Enterococcus faecalis Bacteremia.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2019</year>
            <month>Jul</month>
            <day>16</day>
            <volume>74</volume>
            <issue>2</issue>
            <fpage>193</fpage>
            <page-range>193-201</page-range>
            <pub-id pub-id-type="pmid">31296291</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dahl</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Miro</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Bruun</surname>
                <given-names>NE</given-names>
              </name>
            </person-group>
            <article-title><italic>Enterococcus faecalis</italic> bacteremia: please do the echo.</article-title>
            <source>Aging (Albany NY)</source>
            <year>2019</year>
            <month>Dec</month>
            <day>12</day>
            <volume>11</volume>
            <issue>23</issue>
            <fpage>10786</fpage>
            <page-range>10786-10787</page-range>
            <pub-id pub-id-type="pmid">31831716</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Amat-Santos</surname>
                <given-names>IJ</given-names>
              </name>
              <name>
                <surname>Ribeiro</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Urena</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Allende</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Houde</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>B&#x000e9;dard</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Perron</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>DeLarochelli&#x000e8;re</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Paradis</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Dumont</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Doyle</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mohammadi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>C&#x000f4;t&#x000e9;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>San Roman</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Rod&#x000e9;s-Cabau</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Prosthetic valve endocarditis after transcatheter valve replacement: a systematic review.</article-title>
            <source>JACC Cardiovasc Interv</source>
            <year>2015</year>
            <month>Feb</month>
            <volume>8</volume>
            <issue>2</issue>
            <fpage>334</fpage>
            <page-range>334-346</page-range>
            <pub-id pub-id-type="pmid">25700757</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bayer</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Seidel</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Yoshikawa</surname>
                <given-names>TT</given-names>
              </name>
              <name>
                <surname>Anthony</surname>
                <given-names>BF</given-names>
              </name>
              <name>
                <surname>Guze</surname>
                <given-names>LB</given-names>
              </name>
            </person-group>
            <article-title>Group D enterococcal meningitis. Clinical and therapeutic considerations with report of three cases and review of the literature.</article-title>
            <source>Arch Intern Med</source>
            <year>1976</year>
            <month>Aug</month>
            <volume>136</volume>
            <issue>8</issue>
            <fpage>883</fpage>
            <page-range>883-6</page-range>
            <pub-id pub-id-type="pmid">821410</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kurup</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tee</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>Loo</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Infection of central nervous system by motile Enterococcus: first case report.</article-title>
            <source>J Clin Microbiol</source>
            <year>2001</year>
            <month>Feb</month>
            <volume>39</volume>
            <issue>2</issue>
            <fpage>820</fpage>
            <page-range>820-2</page-range>
            <pub-id pub-id-type="pmid">11158162</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goh</surname>
                <given-names>HMS</given-names>
              </name>
              <name>
                <surname>Yong</surname>
                <given-names>MHA</given-names>
              </name>
              <name>
                <surname>Chong</surname>
                <given-names>KKL</given-names>
              </name>
              <name>
                <surname>Kline</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>Model systems for the study of Enterococcal colonization and infection.</article-title>
            <source>Virulence</source>
            <year>2017</year>
            <month>Nov</month>
            <day>17</day>
            <volume>8</volume>
            <issue>8</issue>
            <fpage>1525</fpage>
            <page-range>1525-1562</page-range>
            <pub-id pub-id-type="pmid">28102784</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Teixeira</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Facklam</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Steigerwalt</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Pigott</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>Merquior</surname>
                <given-names>VL</given-names>
              </name>
              <name>
                <surname>Brenner</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Correlation between phenotypic characteristics and DNA relatedness within Enterococcus faecium strains.</article-title>
            <source>J Clin Microbiol</source>
            <year>1995</year>
            <month>Jun</month>
            <volume>33</volume>
            <issue>6</issue>
            <fpage>1520</fpage>
            <page-range>1520-3</page-range>
            <pub-id pub-id-type="pmid">7650178</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Depardieu</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Perichon</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Courvalin</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Detection of the van alphabet and identification of enterococci and staphylococci at the species level by multiplex PCR.</article-title>
            <source>J Clin Microbiol</source>
            <year>2004</year>
            <month>Dec</month>
            <volume>42</volume>
            <issue>12</issue>
            <fpage>5857</fpage>
            <page-range>5857-60</page-range>
            <pub-id pub-id-type="pmid">15583325</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Martinez</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Bauerle</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Fang</surname>
                <given-names>FC</given-names>
              </name>
              <name>
                <surname>Butler-Wu</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of three rapid diagnostic methods for direct identification of microorganisms in positive blood cultures.</article-title>
            <source>J Clin Microbiol</source>
            <year>2014</year>
            <month>Jul</month>
            <volume>52</volume>
            <issue>7</issue>
            <fpage>2521</fpage>
            <page-range>2521-9</page-range>
            <pub-id pub-id-type="pmid">24808235</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Deck</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Buckner</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Colasante</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Coull</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Crystal</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Latta</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Fuchs</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fuller</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Harris</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Hazen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Klimas</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Lindao</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Meltzer</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Morgan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shepard</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Stevens</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Fiandaca</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Rapid detection of Enterococcus spp. direct from blood culture bottles using Enterococcus QuickFISH method: a multicenter investigation.</article-title>
            <source>Diagn Microbiol Infect Dis</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>78</volume>
            <issue>4</issue>
            <fpage>338</fpage>
            <page-range>338-42</page-range>
            <pub-id pub-id-type="pmid">24439447</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ohlsson</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Ullberg</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ozenci</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of species-specific PCR, Bruker MS, VITEK MS and the VITEK 2 system for the identification of clinical Enterococcus isolates.</article-title>
            <source>Eur J Clin Microbiol Infect Dis</source>
            <year>2012</year>
            <month>Nov</month>
            <volume>31</volume>
            <issue>11</issue>
            <fpage>3073</fpage>
            <page-range>3073-7</page-range>
            <pub-id pub-id-type="pmid">22706514</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baddour</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>WR</given-names>
              </name>
              <name>
                <surname>Bayer</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Fowler</surname>
                <given-names>VG</given-names>
              </name>
              <name>
                <surname>Tleyjeh</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Rybak</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Barsic</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Lockhart</surname>
                <given-names>PB</given-names>
              </name>
              <name>
                <surname>Gewitz</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Levison</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Bolger</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Steckelberg</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Baltimore</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Fink</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>O'Gara</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Taubert</surname>
                <given-names>KA</given-names>
              </name>
              <collab>American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and Stroke Council</collab>
            </person-group>
            <article-title>Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association.</article-title>
            <source>Circulation</source>
            <year>2015</year>
            <month>Oct</month>
            <day>13</day>
            <volume>132</volume>
            <issue>15</issue>
            <fpage>1435</fpage>
            <page-range>1435-86</page-range>
            <pub-id pub-id-type="pmid">26373316</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Athan</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cabiltes</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Coghill</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bowe</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Silent but deadly: patients with enterococcal bacteraemia should be assessed for colorectal neoplasia.</article-title>
            <source>Med J Aust</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>210</volume>
            <issue>2</issue>
            <fpage>86</fpage>
            <pub-id pub-id-type="pmid">30712310</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peric&#x000e0;s</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Corredoira</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Moreno</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a-Pa&#x000ed;s</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Falces</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Rabu&#x000f1;al</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mestres</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Alonso</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Marco</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Quintana</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Almela</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Par&#x000e9;</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Llopis</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Castells</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mir&#x000f3;</surname>
                <given-names>JM</given-names>
              </name>
              <collab>Hospital Cl&#x000ed;nic and Hospital Lucus Augusti Infective Endocarditis Investigators</collab>
            </person-group>
            <article-title>Relationship Between Enterococcus faecalis Infective Endocarditis and Colorectal Neoplasm: Preliminary Results From a Cohort of 154 Patients.</article-title>
            <source>Rev Esp Cardiol (Engl Ed)</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>70</volume>
            <issue>6</issue>
            <fpage>451</fpage>
            <page-range>451-458</page-range>
            <pub-id pub-id-type="pmid">27916708</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Amarnani</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rapose</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Colon cancer and enterococcus bacteremia co-affection: A dangerous alliance.</article-title>
            <source>J Infect Public Health</source>
            <year>2017</year>
            <season>Sep-Oct</season>
            <volume>10</volume>
            <issue>5</issue>
            <fpage>681</fpage>
            <page-range>681-684</page-range>
            <pub-id pub-id-type="pmid">28143799</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <article-title>Choice of antibacterial drugs.</article-title>
            <source>Treat Guidel Med Lett</source>
            <year>2007</year>
            <month>May</month>
            <volume>5</volume>
            <issue>57</issue>
            <fpage>33</fpage>
            <page-range>33-50</page-range>
            <pub-id pub-id-type="pmid">17450114</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Minassian</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Chattopadhyay</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bovill</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Duckworth</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>A comparison between single-dose fosfomycin trometamol (Monuril) and a 5-day course of trimethoprim in the treatment of uncomplicated lower urinary tract infection in women.</article-title>
            <source>Int J Antimicrob Agents</source>
            <year>1998</year>
            <month>Apr</month>
            <volume>10</volume>
            <issue>1</issue>
            <fpage>39</fpage>
            <page-range>39-47</page-range>
            <pub-id pub-id-type="pmid">9624542</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Graninger</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Ragette</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Nosocomial bacteremia due to Enterococcus faecalis without endocarditis.</article-title>
            <source>Clin Infect Dis</source>
            <year>1992</year>
            <month>Jul</month>
            <volume>15</volume>
            <issue>1</issue>
            <fpage>49</fpage>
            <page-range>49-57</page-range>
            <pub-id pub-id-type="pmid">1617073</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stevenson</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>EW</given-names>
              </name>
              <name>
                <surname>Sarubbi</surname>
                <given-names>FA</given-names>
              </name>
            </person-group>
            <article-title>Enterococcal meningitis: report of four cases and review.</article-title>
            <source>Clin Infect Dis</source>
            <year>1994</year>
            <month>Feb</month>
            <volume>18</volume>
            <issue>2</issue>
            <fpage>233</fpage>
            <page-range>233-9</page-range>
            <pub-id pub-id-type="pmid">8161632</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>HAVARD</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>GARROD</surname>
                <given-names>LP</given-names>
              </name>
              <name>
                <surname>WATERWORTH</surname>
                <given-names>PM</given-names>
              </name>
            </person-group>
            <article-title>Deaf or dead? A case of subacute bacterial endocarditis treated with penicillin and neomycin.</article-title>
            <source>Br Med J</source>
            <year>1959</year>
            <month>Mar</month>
            <day>14</day>
            <volume>1</volume>
            <issue>5123</issue>
            <fpage>688</fpage>
            <page-range>688-9</page-range>
            <pub-id pub-id-type="pmid">13629091</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mainardi</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Gutmann</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Acar</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Goldstein</surname>
                <given-names>FW</given-names>
              </name>
            </person-group>
            <article-title>Synergistic effect of amoxicillin and cefotaxime against Enterococcus faecalis.</article-title>
            <source>Antimicrob Agents Chemother</source>
            <year>1995</year>
            <month>Sep</month>
            <volume>39</volume>
            <issue>9</issue>
            <fpage>1984</fpage>
            <page-range>1984-7</page-range>
            <pub-id pub-id-type="pmid">8540703</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Burguer Moreira</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Nastro</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vay</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Famiglietti</surname>
                <given-names>&#x000c1;</given-names>
              </name>
              <name>
                <surname>Rodr&#x000ed;guez</surname>
                <given-names>CH</given-names>
              </name>
            </person-group>
            <article-title>[In vitro activity of ampicillin-ceftriaxone against Enterococcus faecalis isolates recovered from invasive infections].</article-title>
            <source>Rev Argent Microbiol</source>
            <year>2016</year>
            <season>Jan-Mar</season>
            <volume>48</volume>
            <issue>1</issue>
            <fpage>57</fpage>
            <page-range>57-61</page-range>
            <pub-id pub-id-type="pmid">26857425</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gavald&#x000e0;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Torres</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tenorio</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>L&#x000f3;pez</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Zaragoza</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Capdevila</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Almirante</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ruiz</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Borrell</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Gomis</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Pigrau</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Baquero</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Pahissa</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Efficacy of ampicillin plus ceftriaxone in treatment of experimental endocarditis due to Enterococcus faecalis strains highly resistant to aminoglycosides.</article-title>
            <source>Antimicrob Agents Chemother</source>
            <year>1999</year>
            <month>Mar</month>
            <volume>43</volume>
            <issue>3</issue>
            <fpage>639</fpage>
            <page-range>639-46</page-range>
            <pub-id pub-id-type="pmid">10049280</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gavald&#x000e1;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Onrubia</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>G&#x000f3;mez</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Gomis</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Ram&#x000ed;rez</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Len</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Rodr&#x000ed;guez</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Crespo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ru&#x000ed;z</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Pahissa</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides.</article-title>
            <source>J Antimicrob Chemother</source>
            <year>2003</year>
            <month>Sep</month>
            <volume>52</volume>
            <issue>3</issue>
            <fpage>514</fpage>
            <page-range>514-7</page-range>
            <pub-id pub-id-type="pmid">12917251</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gavald&#x000e0;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Len</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Mir&#x000f3;</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Mu&#x000f1;oz</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Montejo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Alarc&#x000f3;n</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>de la Torre-Cisneros</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pe&#x000f1;a</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;nez-Lacasa</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Sarria</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bou</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Aguado</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Navas</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Romeu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Marco</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Torres</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tornos</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Planes</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Falc&#x000f3;</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Almirante</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Pahissa</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone.</article-title>
            <source>Ann Intern Med</source>
            <year>2007</year>
            <month>Apr</month>
            <day>17</day>
            <volume>146</volume>
            <issue>8</issue>
            <fpage>574</fpage>
            <page-range>574-9</page-range>
            <pub-id pub-id-type="pmid">17438316</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miro</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Cervera</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Garcia-de-la-Maria</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Del Rio</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Armero</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Mestres</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Grau</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Marco</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Moreno</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Success of ampicillin plus ceftriaxone rescue therapy for a relapse of Enterococcus faecalis native-valve endocarditis and in vitro data on double beta-lactam activity.</article-title>
            <source>Scand J Infect Dis</source>
            <year>2008</year>
            <volume>40</volume>
            <issue>11-12</issue>
            <fpage>968</fpage>
            <page-range>968-72</page-range>
            <pub-id pub-id-type="pmid">18767002</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peterson</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Lau</surname>
                <given-names>TTY</given-names>
              </name>
              <name>
                <surname>Ensom</surname>
                <given-names>MHH</given-names>
              </name>
            </person-group>
            <article-title>Combination of Ceftriaxone and Ampicillin for the Treatment of Enterococcal Endocarditis: A Qualitative Systematic Review.</article-title>
            <source>Ann Pharmacother</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>51</volume>
            <issue>6</issue>
            <fpage>496</fpage>
            <page-range>496-503</page-range>
            <pub-id pub-id-type="pmid">28166656</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lorenzo</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Kidd</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Jenkins</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Nicolau</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Housman</surname>
                <given-names>ST</given-names>
              </name>
            </person-group>
            <article-title>In vitro activity of ampicillin and ceftriaxone against ampicillin-susceptible Enterococcus faecium.</article-title>
            <source>J Antimicrob Chemother</source>
            <year>2019</year>
            <month>Aug</month>
            <day>01</day>
            <volume>74</volume>
            <issue>8</issue>
            <fpage>2269</fpage>
            <page-range>2269-2273</page-range>
            <pub-id pub-id-type="pmid">31050740</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yim</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Rybak</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Role of Combination Antimicrobial Therapy for Vancomycin-Resistant Enterococcus faecium Infections: Review of the Current Evidence.</article-title>
            <source>Pharmacotherapy</source>
            <year>2017</year>
            <month>May</month>
            <volume>37</volume>
            <issue>5</issue>
            <fpage>579</fpage>
            <page-range>579-592</page-range>
            <pub-id pub-id-type="pmid">28273381</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smith</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Barber</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Raut</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Aboutaleb</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sakoulas</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Rybak</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>&#x003b2;-Lactam combinations with daptomycin provide synergy against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium.</article-title>
            <source>J Antimicrob Chemother</source>
            <year>2015</year>
            <volume>70</volume>
            <issue>6</issue>
            <fpage>1738</fpage>
            <page-range>1738-43</page-range>
            <pub-id pub-id-type="pmid">25645208</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chuang</surname>
                <given-names>YC</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>HY</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>PY</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>SC</given-names>
              </name>
            </person-group>
            <article-title>Daptomycin versus linezolid for the treatment of vancomycin-resistant enterococcal bacteraemia: implications of daptomycin dose.</article-title>
            <source>Clin Microbiol Infect</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>22</volume>
            <issue>10</issue>
            <fpage>890.e1</fpage>
            <page-range>890.e1-890.e7</page-range>
            <pub-id pub-id-type="pmid">27475738</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Becattini</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Moody</surname>
                <given-names>TU</given-names>
              </name>
              <name>
                <surname>Shliaha</surname>
                <given-names>PV</given-names>
              </name>
              <name>
                <surname>Littmann</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Seok</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gjonbalaj</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Eaton</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Fontana</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Amoretti</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wright</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Caballero</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>ZX</given-names>
              </name>
              <name>
                <surname>Jung</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Morjaria</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Leiner</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Qin</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Ramos</surname>
                <given-names>RJJF</given-names>
              </name>
              <name>
                <surname>Cross</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Narushima</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Honda</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Peled</surname>
                <given-names>JU</given-names>
              </name>
              <name>
                <surname>Hendrickson</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Taur</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>van den Brink</surname>
                <given-names>MRM</given-names>
              </name>
              <name>
                <surname>Pamer</surname>
                <given-names>EG</given-names>
              </name>
            </person-group>
            <article-title>Microbiota-derived lantibiotic restores resistance against vancomycin-resistant Enterococcus.</article-title>
            <source>Nature</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>572</volume>
            <issue>7771</issue>
            <fpage>665</fpage>
            <page-range>665-669</page-range>
            <pub-id pub-id-type="pmid">31435014</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jeong</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yun</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>OJ</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>SH</given-names>
              </name>
            </person-group>
            <article-title>Propionate, together with triple antibiotics, inhibits the growth of Enterococci.</article-title>
            <source>J Microbiol</source>
            <year>2019</year>
            <month>Nov</month>
            <volume>57</volume>
            <issue>11</issue>
            <fpage>1019</fpage>
            <page-range>1019-1024</page-range>
            <pub-id pub-id-type="pmid">31659687</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bolocan</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Upadrasta</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bettio</surname>
                <given-names>PHA</given-names>
              </name>
              <name>
                <surname>Clooney</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Draper</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Ross</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Hill</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of Phage Therapy in the Context of <italic>Enterococcus faecalis</italic> and Its Associated Diseases.</article-title>
            <source>Viruses</source>
            <year>2019</year>
            <month>Apr</month>
            <day>20</day>
            <volume>11</volume>
            <issue>4</issue>
            <pub-id pub-id-type="pmid">31010053</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barros</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Melo</surname>
                <given-names>LDR</given-names>
              </name>
              <name>
                <surname>Poeta</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Igrejas</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ferraz</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Azeredo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Monteiro</surname>
                <given-names>FJ</given-names>
              </name>
            </person-group>
            <article-title>Lytic bacteriophages against multidrug-resistant Staphylococcus aureus, Enterococcus faecalis and Escherichia coli isolates from orthopaedic implant-associated infections.</article-title>
            <source>Int J Antimicrob Agents</source>
            <year>2019</year>
            <month>Sep</month>
            <volume>54</volume>
            <issue>3</issue>
            <fpage>329</fpage>
            <page-range>329-337</page-range>
            <pub-id pub-id-type="pmid">31229670</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chatterjee</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>CN</given-names>
              </name>
              <name>
                <surname>Luong</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hullahalli</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>McBride</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Schubert</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Palmer</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Carlson</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Duerkop</surname>
                <given-names>BA</given-names>
              </name>
            </person-group>
            <article-title>Bacteriophage Resistance Alters Antibiotic-Mediated Intestinal Expansion of Enterococci.</article-title>
            <source>Infect Immun</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>87</volume>
            <issue>6</issue>
            <pub-id pub-id-type="pmid">30936157</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r74">
          <label>74</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hullahalli</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Rodrigues</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Palmer</surname>
                <given-names>KL</given-names>
              </name>
            </person-group>
            <article-title>Exploiting CRISPR-Cas to manipulate <italic>Enterococcus faecalis</italic> populations.</article-title>
            <source>Elife</source>
            <year>2017</year>
            <month>Jun</month>
            <day>23</day>
            <volume>6</volume>
            <pub-id pub-id-type="pmid">28644125</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r75">
          <label>75</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Prematunge</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>MacDougall</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Johnstone</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Adomako</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lam</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Robertson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Garber</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>VRE and VSE Bacteremia Outcomes in the Era of Effective VRE Therapy: A Systematic Review and Meta-analysis.</article-title>
            <source>Infect Control Hosp Epidemiol</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>37</volume>
            <issue>1</issue>
            <fpage>26</fpage>
            <page-range>26-35</page-range>
            <pub-id pub-id-type="pmid">26434609</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r76">
          <label>76</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Duan</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Llorente</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Brandl</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Chu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Clarke</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Torralba</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shao</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hernandez-Morales</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lessor</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Rahman</surname>
                <given-names>IR</given-names>
              </name>
              <name>
                <surname>Miyamoto</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ly</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gao</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Kiesel</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hutmacher</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ventura-Cots</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bosques-Padilla</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Verna</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Abraldes</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Vargas</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Altamirano</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Caballer&#x000ed;a</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Shawcross</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Ho</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Louvet</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lucey</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Mathurin</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Garcia-Tsao</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bataller</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Tu</surname>
                <given-names>XM</given-names>
              </name>
              <name>
                <surname>Eckmann</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>van der Donk</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lawley</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>St&#x000e4;rkel</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pride</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Fouts</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Schnabl</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease.</article-title>
            <source>Nature</source>
            <year>2019</year>
            <month>Nov</month>
            <volume>575</volume>
            <issue>7783</issue>
            <fpage>505</fpage>
            <page-range>505-511</page-range>
            <pub-id pub-id-type="pmid">31723265</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r77">
          <label>77</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garrett</surname>
                <given-names>WS</given-names>
              </name>
            </person-group>
            <article-title>Enterococcus in Graft-versus-Host Disease.</article-title>
            <source>N Engl J Med</source>
            <year>2020</year>
            <month>Mar</month>
            <day>12</day>
            <volume>382</volume>
            <issue>11</issue>
            <fpage>1064</fpage>
            <page-range>1064-1066</page-range>
            <pub-id pub-id-type="pmid">32160669</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r78">
          <label>78</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stein-Thoeringer</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Nichols</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Lazrak</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Docampo</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Slingerland</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Slingerland</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Clurman</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Armijo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Gomes</surname>
                <given-names>ALC</given-names>
              </name>
              <name>
                <surname>Shono</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Staffas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Burgos da Silva</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Devlin</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Markey</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Bajic</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pinedo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Tsakmaklis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Littmann</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Pastore</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Taur</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Monette</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Arcila</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Pickard</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Maloy</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wright</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Amoretti</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Fontana</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Pham</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Jamal</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Weber</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sung</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Hashimoto</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Scheid</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Xavier</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Messina</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Romero</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lew</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bush</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bohannon</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hayasaka</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hasegawa</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Vehreschild</surname>
                <given-names>MJGT</given-names>
              </name>
              <name>
                <surname>Cross</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Ponce</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Perales</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Giralt</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Jenq</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Teshima</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Holler</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Chao</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Pamer</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Peled</surname>
                <given-names>JU</given-names>
              </name>
              <name>
                <surname>van den Brink</surname>
                <given-names>MRM</given-names>
              </name>
            </person-group>
            <article-title>Lactose drives <italic>Enterococcus</italic> expansion to promote graft-versus-host disease.</article-title>
            <source>Science</source>
            <year>2019</year>
            <month>Nov</month>
            <day>29</day>
            <volume>366</volume>
            <issue>6469</issue>
            <fpage>1143</fpage>
            <page-range>1143-1149</page-range>
            <pub-id pub-id-type="pmid">31780560</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r79">
          <label>79</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Franz</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Huch</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Abriouel</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Holzapfel</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>G&#x000e1;lvez</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Enterococci as probiotics and their implications in food safety.</article-title>
            <source>Int J Food Microbiol</source>
            <year>2011</year>
            <month>Dec</month>
            <day>02</day>
            <volume>151</volume>
            <issue>2</issue>
            <fpage>125</fpage>
            <page-range>125-40</page-range>
            <pub-id pub-id-type="pmid">21962867</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r80">
          <label>80</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ben Bra&#x000ef;ek</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Smaoui</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Enterococci: Between Emerging Pathogens and Potential Probiotics.</article-title>
            <source>Biomed Res Int</source>
            <year>2019</year>
            <volume>2019</volume>
            <fpage>5938210</fpage>
            <pub-id pub-id-type="pmid">31240218</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r81">
          <label>81</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Faron</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Ledeboer</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Buchan</surname>
                <given-names>BW</given-names>
              </name>
            </person-group>
            <article-title>Resistance Mechanisms, Epidemiology, and Approaches to Screening for Vancomycin-Resistant Enterococcus in the Health Care Setting.</article-title>
            <source>J Clin Microbiol</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>54</volume>
            <issue>10</issue>
            <fpage>2436</fpage>
            <page-range>2436-47</page-range>
            <pub-id pub-id-type="pmid">27147728</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r82">
          <label>82</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weber</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Oriola</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Huskins</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Noskin</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Harriman</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Olmsted</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Bonten</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lundstrom</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Climo</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Roghmann</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Karchmer</surname>
                <given-names>TB</given-names>
              </name>
              <collab>Society for Healthcare Epidemiology of America</collab>
              <collab>Association of Professionals in Infection Control and Epidemiology</collab>
            </person-group>
            <article-title>Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: position statement from the Joint SHEA and APIC Task Force.</article-title>
            <source>Infect Control Hosp Epidemiol</source>
            <year>2007</year>
            <month>Mar</month>
            <volume>28</volume>
            <issue>3</issue>
            <fpage>249</fpage>
            <page-range>249-60</page-range>
            <pub-id pub-id-type="pmid">17326014</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r83">
          <label>83</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Muto</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Jernigan</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Ostrowsky</surname>
                <given-names>BE</given-names>
              </name>
              <name>
                <surname>Richet</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Jarvis</surname>
                <given-names>WR</given-names>
              </name>
              <name>
                <surname>Boyce</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Farr</surname>
                <given-names>BM</given-names>
              </name>
              <collab>SHEA</collab>
            </person-group>
            <article-title>SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus.</article-title>
            <source>Infect Control Hosp Epidemiol</source>
            <year>2003</year>
            <month>May</month>
            <volume>24</volume>
            <issue>5</issue>
            <fpage>362</fpage>
            <page-range>362-86</page-range>
            <pub-id pub-id-type="pmid">12785411</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r84">
          <label>84</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mac</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fitzpatrick</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Johnstone</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sander</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Vancomycin-resistant enterococci (VRE) screening and isolation in the general medicine ward: a cost-effectiveness analysis.</article-title>
            <source>Antimicrob Resist Infect Control</source>
            <year>2019</year>
            <volume>8</volume>
            <fpage>168</fpage>
            <pub-id pub-id-type="pmid">31687132</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r85">
          <label>85</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>De Angelis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cataldo</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>De Waure</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Venturiello</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>La Torre</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cauda</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Carmeli</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Tacconelli</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Infection control and prevention measures to reduce the spread of vancomycin-resistant enterococci in hospitalized patients: a systematic review and meta-analysis.</article-title>
            <source>J Antimicrob Chemother</source>
            <year>2014</year>
            <month>May</month>
            <volume>69</volume>
            <issue>5</issue>
            <fpage>1185</fpage>
            <page-range>1185-92</page-range>
            <pub-id pub-id-type="pmid">24458513</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r86">
          <label>86</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vehreschild</surname>
                <given-names>MJGT</given-names>
              </name>
              <name>
                <surname>Haverkamp</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Biehl</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Lemmen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>F&#x000e4;tkenheuer</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Vancomycin-resistant enterococci (VRE): a reason to isolate?</article-title>
            <source>Infection</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>47</volume>
            <issue>1</issue>
            <fpage>7</fpage>
            <page-range>7-11</page-range>
            <pub-id pub-id-type="pmid">30178076</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127216.r87">
          <label>87</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>LeDell</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Muto</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Jarvis</surname>
                <given-names>WR</given-names>
              </name>
              <name>
                <surname>Farr</surname>
                <given-names>BM</given-names>
              </name>
            </person-group>
            <article-title>SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus.</article-title>
            <source>Infect Control Hosp Epidemiol</source>
            <year>2003</year>
            <month>Sep</month>
            <volume>24</volume>
            <issue>9</issue>
            <fpage>639</fpage>
            <page-range>639-41</page-range>
            <pub-id pub-id-type="pmid">14510243</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
